ConcertAI: ASCO 2024 study uses ConcertAI Oncology Dataset to find earlier treatment with oliparib monotherapy may improve duration of therapy and overall survival ...Middle East

CAMBRIDGE, Mass., May 29, 2024 /PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the results of the study to be presented at the ASCO Annual Meeting 2024 utilizing its real-world...

Hence then, the article about concertai asco 2024 study uses concertai oncology dataset to find earlier treatment with oliparib monotherapy may improve duration of therapy and overall survival was published today ( Wednesday 29/05/2024 - 08:05 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ConcertAI: ASCO 2024 study uses ConcertAI Oncology Dataset to find earlier treatment with oliparib monotherapy may improve duration of therapy and overall survival )

Also on site :

• 11 Colorado schools receive threats, several on lockdown
• Aurora man arrested on suspicion of starting massive Leetsdale Drive fire
• US Visa Processing Frozen By Trump Administration in 75 Countries